Botox: Should It Ever Be Used? (Surgery Perspective)
Foregut: The Journal of the American Foregut Society(2022)
摘要
Botox was first described for its use in achalasia in 1995, demonstrating that it could be safely used to temporarily improve the outflow obstruction and relieve patient symptoms such as dysphagia, regurgitation and chest pain for several months. Though highly effective, Botox loses efficacy long-term compared to other endoscopic or surgical treatments, with the majority requiring repeated injections. Therefore, Botox is not favored as a long-term treatment strategy for patients with otherwise surgically treatable achalasia. It instead serves as an alternative to bridge patients to definitive treatment, to treat poor surgical candidates, and to confirm achalasia diagnosis in complex patients.
更多查看译文
关键词
surgery perspective
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要